166 related articles for article (PubMed ID: 34738326)
1. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.
Yang J; Zeng Z; Qiao L; Jiang X; Ma J; Wang J; Ye S; Ma Q; Wei J; Wu M; Huang X; Ma D; Gao Q
Mol Cancer Res; 2019 Oct; 17(10):2015-2028. PubMed ID: 31308149
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin-4C is upregulated in epithelial ovarian cancer.
Huang S; Han S; Zhang J; Zhong Z; Wang J
Oncol Lett; 2020 Apr; 19(4):3333-3338. PubMed ID: 32256827
[TBL] [Abstract][Full Text] [Related]
4. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 4C: A Novel Component of B-Cell Polarization in Th2-Driven Immune Responses.
Xue D; Desjardins M; Kaufman GN; Béland M; Al-Tamemi S; Ahmed E; Tao S; Friedel RH; Mourad W; Mazer BD
Front Immunol; 2016; 7():558. PubMed ID: 28003812
[TBL] [Abstract][Full Text] [Related]
6. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
7. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
[TBL] [Abstract][Full Text] [Related]
8. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
[TBL] [Abstract][Full Text] [Related]
9. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection.
Moon PG; Lee JE; Cho YE; Lee SJ; Jung JH; Chae YS; Bae HI; Kim YB; Kim IS; Park HY; Baek MC
Clin Cancer Res; 2016 Apr; 22(7):1757-66. PubMed ID: 26603257
[TBL] [Abstract][Full Text] [Related]
10. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1.
Hung YH; Lai MD; Hung WC; Chen LT
Am J Cancer Res; 2022; 12(2):713-728. PubMed ID: 35261797
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL
Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X; Zhang C; Tian Y
J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
[TBL] [Abstract][Full Text] [Related]
15. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
Smeester BA; Slipek NJ; Pomeroy EJ; Bomberger HE; Shamsan GA; Peterson JJ; Crosby MR; Draper GM; Becklin KL; Rahrmann EP; McCarthy JB; Odde DJ; Wood DK; Largaespada DA; Moriarity BS
Oncogene; 2020 Jan; 39(5):1049-1062. PubMed ID: 31582836
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C.
Wei JC; Yang J; Liu D; Wu MF; Qiao L; Wang JN; Ma QF; Zeng Z; Ye SM; Guo ES; Jiang XF; You LY; Chen Y; Zhou L; Huang XY; Zhu T; Meng L; Zhou JF; Feng ZH; Ma D; Gao QL
Clin Cancer Res; 2017 Jan; 23(1):214-224. PubMed ID: 27401250
[TBL] [Abstract][Full Text] [Related]
17. Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.
Hao W; Zhang X; Xiu B; Yang X; Hu S; Liu Z; Duan C; Jin S; Ying X; Zhao Y; Han X; Hao X; Fan Y; Johnson H; Meng D; Persson JL; Zhang H; Feng X; Huang Y
Tumour Biol; 2016 Jul; 37(7):8909-16. PubMed ID: 26753956
[TBL] [Abstract][Full Text] [Related]
18. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells.
Gurrapu S; Franzolin G; Fard D; Accardo M; Medico E; Sarotto I; Sapino A; Isella C; Tamagnone L
Sci Signal; 2019 Aug; 12(595):. PubMed ID: 31431542
[TBL] [Abstract][Full Text] [Related]
19. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
